Prestige Consumer Healthcare Inc.·4

Nov 19, 4:01 PM ET

Lombardi Ronald M. 4

4 · Prestige Consumer Healthcare Inc. · Filed Nov 19, 2024

Insider Transaction Report

Form 4
Period: 2024-11-18
Lombardi Ronald M.
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock, par value $0.01 per share

    2024-11-18$57.18/sh+48,512$2,773,916369,464 total
  • Sale

    Common Stock, par value $0.01 per share

    2024-11-18$82.41/sh33,725$2,779,277320,952 total
  • Exercise/Conversion

    Common Stock, par value $0.01 per share

    2024-11-18$56.11/sh+33,725$1,892,310354,677 total
  • Sale

    Common Stock, par value $0.01 per share

    2024-11-18$82.67/sh48,512$4,010,487320,952 total
  • Exercise/Conversion

    Employee Stock Options (right to buy)

    2024-11-1833,7255,662 total
    Exercise: $56.11Exp: 2027-05-08Common Stock (33,725 underlying)
  • Exercise/Conversion

    Employee Stock Options (right to buy)

    2024-11-1848,5125,213 total
    Exercise: $57.18Exp: 2026-05-09Common Stock (48,512 underlying)
Footnotes (4)
  • [F1]Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $81.50 to $82.67.
  • [F2]Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $81.50 to $82.41.
  • [F3]The options vested in three installments each of 17,908 shares on May 9, 2017 and May 9, 2018 and 17,909 shares on May 9, 2019.
  • [F4]The options vested in three equal installment each of 13,129 shares on May 8, 2018, May 8, 2019 and May 8, 2020.

Documents

1 file
  • 4
    tm2428889-1_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT